Cardiovascular abnormalities in Turner's syndrome: What prevention?

Archives of Cardiovascular Diseases

Volumn 101, Issue 7-8, 2008, Pages 485-490

  Dulac, Yves ^a   Pienkowski, Catherine ^a   Abadir, Sylvia ^a   Tauber, Maité ^a   Acar, Philippe ^a  

^a TOULOUSE UNIVERSITY HOSPITAL   (France)

Author keywords

Aortic dissection; Bicuspid aortic valve; Coarctation of the aorta; Hypertension; Turner

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; GROWTH HORMONE;

AORTA ANOMALY; AORTA COARCTATION; AORTA DISSECTION; AORTA STENOSIS; AORTA VALVE DISEASE; ASCENDING AORTA; BICUSPID AORTIC VALVE; BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MALFORMATION; CARDIOVASCULAR RISK; CARDIOVASCULAR SURGERY; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CONGENITAL HEART DISEASE; DIABETES MELLITUS; DISEASE EXACERBATION; DISEASE PREDISPOSITION; DRUG EFFICACY; DYSLIPIDEMIA; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; ENDOCARDITIS; ESSENTIAL HYPERTENSION; ESTROGEN DEFICIENCY; FETUS ECHOGRAPHY; FOLLOW UP; HEART HEMODYNAMICS; HEART MUSCLE CONDUCTION DISTURBANCE; HOLTER MONITORING; HUMAN; HYPERTENSION; LIFE EXPECTANCY; MARFAN SYNDROME; MEDICAL ASSESSMENT; MORTALITY; NUCLEAR MAGNETIC RESONANCE IMAGING; OBESITY; PATIENT MONITORING; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PREGNANCY COMPLICATION; PRENATAL DIAGNOSIS; PROGNOSIS; RETROSPECTIVE STUDY; REVIEW; RISK ASSESSMENT; RISK FACTOR; RISK MANAGEMENT; SURVIVAL RATE; TURNER SYNDROME;

EID: 56049100043     PISSN: 18752136     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.acvd.2008.05.007     Document Type: Review

References (46)

1. Ostberg JE, Conway GS. Adulthood in women with Turner's syndrome. Horm Res 2003;59:211-21.
2. Gotzsche C, Krag-Olsen B. Prevalence of cardiovascular malformations and association with karyotypes in Turner's syndrome. Arch Dis Child 1994;71:433-6.
3. Mazzanti L, Prandstraller D, Tassinari D, et al. Heart disease in Turner's syndrome. Helv Paediatr Acta 1988;43;25-31.
4. Volkl TM, Degenhardt K, Koch A, Simm D, Dorr HG, Singer H. Cardiovascular anomalies in children and young adults with Ullrich-Turner's syndrome: the Erlangen experience. Clin Cardiol 2005;28:88-92.
5. Castro AV, Okoshi K, Ribeiro SM, et al. Cardiovascular assessment of patients with Ullrich-Turner's Syndrome on Doppler echocardiography and magnetic resonance imaging. Ar Qbras Cardiol 2002;78:51-8.
6. Ho VB, Bakalov VK, Cooley M, et al. Major vascular anomalies in Turner's syndrome: prevalence and magnetic resonance angiographic features. Circulation 2004;110:1694-700.
7. Ostberg JE, Brookes JAS, McCarthy C, Halcox J, Conway GS. A Comparison of echocardiography and magnetic resonance imaging in cardiovascular screening of adults with Turner's syndrome. J Clin Endocrinol Metab 2004;89:5966-71.
8. Bondy CA, Turner's Syndrome Study Group. Care of girls and women with Turner's syndrome: a guideline of the Turner's syndrome study group. J Clin Endocrinol Metab 2007;92: 10-25.
9. Van Wassenaer AG, Lubbers LJ, Losekoot G. Partial abnormal pulmonary venous return in Turner's syndrome. Eur J Pediatr 1988;148:101-3.
10. Bechtold SM, Dalla Pozza R, Becker A, Meidert A, Dohlemann C, Schwarz HP. Partial anomalous pulmonary vein connection: an underestimated cardiovascular defect in Ullrich-Turner's syndrome. Eur J Pediatr 2004;163:158-62.
11. Surerus E, Huggon IC, Allan LD. Turner's syndrome in fetal life. Ultrasound Obstet Gynecol 2003;22:264-7.
12. Miyabara S, Nakayama M, Suzumori K, Yonemitsu N, Sugihara H. Developmental analysis of cardiovascular system of 45, X fetuses with cystic hygroma. Am J Med Genet 1997;68: 135-41.
13. Clark EB. Neck web and congenital heart defects: a pathogenic association in 45 X-O Turner's syndrome. Teratology 1984;29:355-61.
14. Loscalzo ML, Van PL, Ho VB, et al. Association between fetal lymphedema and congenital cardiovascular defects in Turner's syndrome. Pediatrics 2005;115:732-5.
15. Matura LA, Ho VB, Rosing DR, Bondy CA. Aortic dilatation and dissection in Turner's syndrome. Circulation 2007;116:1663-70.
16. Boucher CA, Sargent CA, Ogata T, Affara NA. Breakpoint analysis of Turner's patients with partial Xp deletions: implications for the lymphoedema gene location. J Med Genet 2001;38:591-8.
17. Silberbach M. Making treatment decisions for those with congenital heart disease in Turner's syndrome: the need for evidence-based medecine. International Congress series 2006;1298:131-6.
18. Fejzic van Oort A. Fatal dissection of the descending aorta after implantation of a stent in a 19-years-old female with Turner's syndrome. Cardiol Young 2005;15:529-31.
19. Roman MJ, Devereux RB, Kramer-Fox R, O'Loughlin J. Two-dimensional echocardiographic aortic root dimensions in normal children and adults. Am J Cardiol 1989;64: 507-12.
20. Chalard F, Ferey S, Teinturier C, Kalifa G. Aortic dilatation in Turner's syndrome: the role of MRI in early recognition. Pediatr Radiol 2005;35:323-6.
21. Elsheikh M, Casadei B, Conway GS, Wass JA. Hypertension is a major risk factor for aortic root dilatation in women with Turner's syndrome. Clin Endocrinol 2001;54:69-73.
22. Baguet JP, Douchin S, Pierre H, Rossignol AM, Bost M, Mallion JM. Structural and functional abnormalities of large arteries in Turner's syndrome. Heart 2005;91:1442-6.
23. Lin AE, Lippe B, Rosenfeld RG. Further delineation of aortic dilation, dissection, and rupture in patients with Turner's syndrome. Pediatrics 1998;102:E12.
24. Ostberg JE, Donald AE, Halcox JPJ, Storry C, McCarthy C, Conway GS. Vasculopathy in Turner's syndrome: arterial dilatation and intimal thickening without endothelial dysfunction. J Clin Endocrinol Metab 2005;90:5161-6.
25. Loeys BL, Schwarze U, Holm T, et al. Aneuvrysm syndromes caused by mutations in the TGFb receptor. N Engl J Med 2006;355:788-98.
26. Habashi JP, Judge DP, Holm TM, et al. Losartan, an AT1 antagonist, prevents artic aneuvrysm model of Marfan syndrome. Science 2006;312:117-21.
27. Gravhott CH, Juul S, Naeraa RW, Hansen J. Morbidity in Turner's syndrome. J Clin Epidemiol 1998;51:147-58.
28. Gravholt CH, Landin-Wilhelmsen K, Stochholm K, et al. Clinical and epidemiological description of aortic dissection in Turner's syndrome. Cardiol Young 2006;16:430-6.
29. Carlson M. Silberbach M. dissection of the aorta in Turner's syndrome: two cases and review of 85 cases in the literature. J Med Genet 2007;44:745-9.
30. Sybert VP. Cardiovascular malformations and complications in Turner's syndrome. Pediatrics 1998;101:E11.
31. Karnis MF, Zimon AE, Lalwani SI, Timmreck LS, Klipstein S, Reindollar RH. Risk of death in pregnancy achieved through ovocyte donation in patients with Turner's syndrome: a national survey. Fertil Steril 2003;80:498-501.
32. Nathwani NC, Unwin R, Brook CG, Hindmarsh PC. Blood pressure and Turner's syndrome. Clin Endocrinol 2000;52:363-70.
33. Gravholt CH,- Hjerrild B. Hypertension and ischemic cardiovascular disease in Turner's syndrome. International congress series 2006;1298:174-9.
34. Nathwani NC, Unwin R, Brook CG, Hindmarsh PC. The influence of renal and cardiovascular abnormalities on blood pressure in Turner's syndrome. Clin Endocrinol 2000;52:371-7.
35. Gravholt CH, Hansen KW, Erlandsen M, Ebbehoj E, Christiansen JS. Nocturnal hypertension and impaired sympathovagal tone in Turner's syndrome. J Hypertens 2006;24:353-60.
36. Bondy CA, Ceniceros I, Van PL, Bakalov VK, Rosing DR. Prolonged rate-corrected QT interval and other electrocardiogram abnormalities in girls with Turner's syndrome. Pediatrics 2006;118:1220-5.
37. Radetti G, Crepaz R, Milanesi O, et al. Cardiac performance in Turner's syndrome patients on growth hormone therapy. Horm Res 2001;55:240-4.
38. Bondy CA, Van PL, Bakalov VK, Ho VB. Growth hormone treatment and aortic dimensions in Turner's syndrome. J Clin Endocrinol Metab 2006;91:1785-8.
39. Van den Berg J, Bannink EM, Wielopolski PA, et al. Aortic distensibility and dimensions and the effects of growth hormone treatment in the Turner's syndrome. Am J Cardiol 2006;97:1644.
40. Haute Autorité de santé. PNDS syndrome de Turner. Saint-Denis-La-Plaine. France: HAS 2008.
41. Ilyas M, Chu C, Ettles D, Mathew V, Atkin S. Evaluation by magnetic resonance imaging of aortic dilatation and coarctation in adult Turner's syndrome patients. Clin Endocrinol 2006;65:154-7.
42. Gravholt CH, Naeraa RW, Nyholm B, et al. Glucose metabolism, lipid metabolism, and cardiovascular risk factors in adult Turner's syndrome. The impact of sex hormone replacement. Diabetes Care 1998;21:1062-70.
43. Van PL, Bakalov VK, Zinn AR, Bondy CA. Maternal X chromosome, visceral adiposity, and lipid profile. JAMA 2006;295: 1373-4.
44. Ostberg JE, Attar MJ, Mohamed-Ali V, Conway GS. Adipokine dysregulation in Turner's syndrome: comparison of circulating interleukin-6 and leptin concentrations with measures of adiposity and C-reactive protein. J Clin Endocrinol Metab 2005;90:2948-53.
45. Shores J, Berger KR, Murphy EA, Pyeritz RE. Progression of aortic dilatation and the benefit of long-term β-adrenergic blockade in Marfan's syndrome. N Engl J Med 1994;330: 1335-41.
46. Practice Committee of the American Society for Reproductive Medicine. Increased maternal cardiovascular mortality associated with pregnancy in women with Turner's syndrome. Fertility and sterility 2006;86:S127-8.